Suchergebnisse - "Bagamian, Karoun H"

PubPharm (27)

1

Reassessing potential economic value and health impact of effective Shigella vaccines

enthalten in: Bulletin of the World Health Organization | 2024

von Hausdorff, W. | Anderson, J. | Bourgeois, A. | +8

2

Vaccine value profile for Shigella

enthalten in: Vaccine | 2023

von Hausdorff, W. | Anderson, J. | Bagamian, K. | +6

3

Vaccine value profile for enterotoxigenic Escherichia coli (ETEC)

enthalten in: Vaccine | 2023

von Khalil, I. | Anderson, J. | Bagamian, K. | +7

4

Shigella and childhood stunting : Evidence, gaps, and future research directions

enthalten in: PLoS neglected tropical diseases | 2023

von Bagamian, K. | Anderson Iv, J. | Blohm, G. | +1

5

Potential impact and cost-effectiveness of Shigella vaccination in 102 low-income and middle-income countries in children aged 5 years or younger : a modelling study

enthalten in: The Lancet. Global health | 2023

von Anderson, J. | Bagamian, K. | Pecenka, C. | +4

6

Projecting the long-term economic benefits of reducing Shigella-attributable linear growth faltering with a potential vaccine : a modelling study

enthalten in: The Lancet. Global health | 2023

von Puett, C. | Anderson, J. | Bagamian, K. | +4

CommentIn: Lancet Glob Health. 2023 Jun;11(6):e807-e808. - PMID 37202009

7

Could a Shigella vaccine impact long-term health outcomes? : Summary report of an expert meeting to inform a Shigella vaccine public health value proposition, March 24 and 29, 2021

enthalten in: Vaccine: X | 2022

von Bagamian, K. | Puett, C. | Anderson, J. | +16

8

Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Nigeria

enthalten in: PloS one | 2020

von Anderson, J. | Pecenka, C. | Bagamian, K. | +1

9

Heterogeneity in enterotoxigenic Escherichia coli and shigella infections in children under 5 years of age from 11 African countries : a subnational approach quantifying risk, mortality, morbidity, and stunting

enthalten in: The Lancet. Global health | 2020

von Bagamian, K. | Anderson, J. | Muhib, F. | +4

CommentIn: Lancet Glob Health. 2020 Jan;8(1):e14-e15. - PMID 31734155

10

Potential impact and cost-effectiveness of future ETEC and Shigella vaccines in 79 low- and lower middle-income countries

enthalten in: Vaccine: X | 2019

von Anderson, J. | Bagamian, K. | Muhib, F. | +5